Glycomics Market Witnessing a CAGR of 12.5% from 2023 to 2032, owing to increasing use of glycans as biomarker | insightSLICE
Global sales of Glycomics were estimated to be US$ 1.21 billion in 2021 and to increase at a CAGR of 12.5% from 2023 to 2032.
Access the sample report: https://www.insightslice.com/request-sample/1291
Benefits of glycomics in clinical setting:
Glycomics is the comprehensive study of the composition and purpose of glycans in a particular cell or organism. All living things produce glycans, also known as polysaccharides, which are polymers consisting of carbohydrates. Glycans are crucial biomolecules that support system regulation, energy storage, and structure.
In accordance with their natural source, glycans can be classified as a plant, animal, or microbial. Drug development, immunotherapy, and diagnosis are among the typical uses for glycomics.
Glycomics uses a variety of methods, such as high-performance liquid chromatography (HPLC) and matrix-assisted laser desorption ionization-time of flight spectrometry (MALDI-TOF-MS), to measure or define the glycome of a tissue, cell, or organism.
The key players of the Global Glycomics Market are:
The major players covered in the glycomics market report are Bruker, ProZyme, WATERS, Shimadzu Corporation, Thermo Fisher Scientific, Merck & Co Inc, Beth Israel Deaconess Medical Center, Asparia Glycomics, Vector Laboratories, Agilent Technologies, New England Biolabs, Glyconet Berlin Brandenburg eV, GlySign, Canadian Glycomics Network, University of Georgia, GlycoDisplay, Glycodiag, RayBiotech, Glyco Expression Technologies Inc., Laboratorios farmaceuticos rovi SA, and others.
Read more about the report inclusions: https://www.insightslice.com/glycomics-market
Several factors will promote market growth:
The ultimate glycan structure changes as a result of changes in the activity of the enzymes implicated in glycan production. So, in addition to looking at a cell’s genome, glycan analysis can be used to monitor changes brought on by the environment.
These investigations are used to find new medicines and diagnose diseases. This is among the primary drivers of market expansion. The N-linked glycans of cancerous cells and viruses are altered by a number of novel glycoside inhibitors that are currently on the market.
disorders caused by deficits such as Tay-Sachs syndrome, Gaucher disorder, and most critically, hyperglycemia, such enzymes are often used therapeutically to direct antifungal, antibiotic, and anti-cancer actions.
According to many research studies, cancer cells’ epigenetic control of glycans causes the development of novel glycan patterns. These novel glycans are produced as a result of the methods cancer cells adopt to avoid the immune system’s response.
To better understand the roles played by particular glycan cancer epitopes, researchers have developed genetically altered cell models. Therefore, it is projected that these variables will fuel market expansion over the projection period.
Effect of Covid-19 pandemic on glycomics market:
In order to create novel particles, substances, and vaccines predicated on glycan data gathering for containing the spread and treating seriously ill patients, biopharmaceutical and drug industries have had numerous chances to boost their research and development expenditures as a result of the global COVID-19 pandemic.
Clinical trials are becoming more common, and with that comes a greater demand for pharmaceutical and biotechnology companies to market new glycomics-based enzymes. High expenditures incurred because of the instruments and methods needed to analyze glycan data are anticipated to restrain market expansion.
The worldwide glycomics market is projected to be constrained by a lack of qualified personnel to carry out glycan data analysis processes including MALDI-TOF-MS and HPLC.
Regional performance of Glycomics Market
Due to the presence of major biopharmaceutical and medical device firms like Merck KGaA, Agilent Technologies, Danaher, and Thermo Fisher Scientific in North America, the region held the greatest market share in 2018.
The geographical market has been pushed by the existence of well-established medical infrastructure and the availability of cutting-edge products. Government support for R&D initiatives is yet another important element driving the development of the glycobiology market in this area.
Proceed to purchase: https://www.insightslice.com/buy-now/1291
Due to its fast-growing economies, the presence of major pharmaceutical companies, and its changing healthcare network, Latin America is expected to experience consistent growth. Brazil is anticipated to grow at a healthy CAGR over the course of the projection period as a result of rising research in life science and evolving healthcare systems.
Due to unmet market prospects, Asia Pacific is anticipated to have the second-fastest expanding regional market throughout the forecast period. Glycomics has dramatically increased in the area as a result of the region’s developing pharmaceutical and biopharmaceutical sectors.
Additionally, Contract Research Organizations (CROs) expenditures in the discovery and manufacturing of pharmaceuticals and biologic drugs are anticipated to boost the expansion of the Asia Pacific glycomics industry.
With its importance in contemporary biotechnology and access to cutting-edge techniques, glycoscience is expected to give European bio-based enterprises a strategic advantage on a global scale.
The European Glycoscience Network (EGSF) was created as a result of initiatives to tackle cross-disciplinary integrative connections with international glycoscience networks established in the United States.
Global Glycomics Market Key Segments:
- Mass spectrometry instruments
- Chromatography instruments
- Electrophoresis instruments
- NMR instruments
- HPLC columns
- Glycan releasing kits
- glycan labeling kits
- glycan purification kits
- glycan detection kits
- glycan enrichment kits
- glycan sample preparation kits
- Other carbohydrates
- Drug Discovery & Development
- Other Applications
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- North America
- United States
- Rest of North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Rest of South America
Global Anaesthesia Devices Market: https://www.insightslice.com/anaesthesia-devices-market
Global Menotropin Market: https://www.insightslice.com/menotropin-market
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at email@example.com.
+1 707 736 6633